Browsing Tag
MYQORZO
2 posts
Myqorzo could expand across the HCM spectrum after Cytokinetics delivers pivotal ACACIA-HCM results
Cytokinetics plans an FDA filing after aficamten succeeds in non-obstructive HCM. See what ACACIA-HCM could mean for Myqorzo growth.
FDA approves Cytokinetics’ MYQORZO for obstructive HCM after SEQUOIA-HCM trial success
FDA approves Cytokinetics’ aficamten for obstructive HCM. Find out what this means for cardiologists, patients, and rival Camzyos as MYQORZO prepares to launch.